Symbiotec Pharmalab has raised Rs 526.20 crore from anchor investors ahead of its Rs 1,757 crore IPO opening August 24. The pharmaceutical company has set a Rs 938-988 price band, with proceeds from the fresh issue earmarked for debt repayment.
Save my name, email, and website in this browser for the next time I comment.
Your Name (required)
Your Email (required)
Subject
Your Message
WhatsApp us
